Boards
Our Board of Directors plays a critical role in the success of BII. The members are responsible for the overall management and strategy of BII and serves to safeguard the interests of our foundation in accordance with our purpose: To bring science to life.
Our Scientific Advisory Board provides BII with high-level expertise by way of strategic guidance during times of innovation, regulatory shifts or scientific development.
Board of Directors
Chair
Marianne Philip
Partner and Lawyer at Kromann Reumert
Deputy Chair
Robert Urban
Consultant
Member
Hans Schambye
CEO of Galecto
Member
Mads Krogsgaard Thomsen
CEO of Novo Nordisk Foundation
Member
Martin Bonde
CEO of Akylox Therapeutics, Venture Partner at BioOrigin
Member
Regina Hodits
Managing Director at Angelini Ventures
Scientific Advisory Board
Chair
Dr. Robert Langer
Massachusetts Institute of Technology
Member
Dr. Christina Smolke
Stanford University
Member
Dr. Eran Segal
Weizmann Institute of Science
Member
Dr. Feng Zhang
Massachusetts Institute of Technology
Member
Dr. Mathias Uhlén
KTH Royal Institute of Technology
Member
Dr. Sang Yup Lee
Korea Advanced Institute of Science and Technology
